These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6097311)

  • 1. Lithium's effects on muscarinic receptor binding parameters: a relationship to therapeutic efficacy?
    Dilsaver SC
    Biol Psychiatry; 1984 Nov; 19(11):1551-65. PubMed ID: 6097311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cholinergic role in the mechanism of lithium in mania.
    Tollefson GD; Senogles S
    Biol Psychiatry; 1983 Apr; 18(4):467-79. PubMed ID: 6860721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of lithium on [3H](-)quinuclidinyl benzilate [( 3H](-)QNB) binding to rat brain muscarinic cholinergic receptors.
    Hruska RE; Ludmer LM; Pert A; Bunney WE
    J Neurosci Res; 1984; 11(2):171-7. PubMed ID: 6423831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced dark-adaptation: an indication of lithium's neuronal action in humans.
    Emrich HM; Zihl J; Raptis C; Wendl A
    Am J Psychiatry; 1990 May; 147(5):629-31. PubMed ID: 2327491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms underlying mood stabilization in manic-depressive illness: the phenotype challenge.
    Ikonomov OC; Manji HK
    Am J Psychiatry; 1999 Oct; 156(10):1506-14. PubMed ID: 10518159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness.
    Manji HK; Moore GJ; Chen G
    J Clin Psychiatry; 2000; 61 Suppl 9():82-96. PubMed ID: 10826666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.
    Manji HK; Bebchuk JM; Moore GJ; Glitz D; Hasanat KA; Chen G
    J Clin Psychiatry; 1999; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurobiology of lithium: an update.
    Lenox RH; McNamara RK; Papke RL; Manji HK
    J Clin Psychiatry; 1998; 59 Suppl 6():37-47. PubMed ID: 9674936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo imaging of the pharmacodynamics and pharmacokinetics of lithium.
    Kilts CD
    J Clin Psychiatry; 2000; 61 Suppl 9():41-6. PubMed ID: 10826660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithium enhances neuronal muscarinic excitation by presynaptic facilitation.
    Evans MS; Zorumski CF; Clifford DB
    Neuroscience; 1990; 38(2):457-68. PubMed ID: 2175856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lithium chloride: protective and antisecretory properties in rats.
    Wong RK; Boedeker B; Hickey TM; Wilkinson DS; Johnson LF
    Gastroenterology; 1984 Aug; 87(2):362-71. PubMed ID: 6329891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lithium augments fos protoonocogene expression in PC12 pheochromocytoma cells: implications for therapeutic action of lithium.
    Kalasapudi VD; Sheftel G; Divish MM; Papolos DF; Lachman HM
    Brain Res; 1990 Jun; 521(1-2):47-54. PubMed ID: 2119851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic induction of cholinergic system up-regulation and supersensitivity in affective disorders research.
    Dilsaver SC
    J Clin Psychopharmacol; 1986 Apr; 6(2):65-74. PubMed ID: 3517080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation of lithium's behavioral effect by inositol uptake inhibitors.
    Einat H; Kofman O; Itkin O; Lewitan RJ; Belmaker RH
    J Neural Transm (Vienna); 1998; 105(1):31-8. PubMed ID: 9588758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electroconvulsive shock and neurotransmitter receptors: implications for mechanism of action and adverse effects of electroconvulsive therapy.
    Lerer B
    Biol Psychiatry; 1984 Mar; 19(3):361-83. PubMed ID: 6144329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of PKC alpha by lithium in vitro.
    Bitran JA; Manji HK; Potter WZ; Gusovsky F
    Psychopharmacol Bull; 1995; 31(2):449-52. PubMed ID: 7491404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Calcium antagonists and lithium in preventive treatment of manic-depressive disorder].
    Sarfati Y; Spadone C; Vanelle JM; Lôo H
    Encephale; 1996; 22(2):149-53. PubMed ID: 8706625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological perturbation of cholinergic systems: applications to the study of pathophysiological mechanisms in affective disorders.
    Dilsaver SC
    Hillside J Clin Psychiatry; 1988; 10(1):38-54. PubMed ID: 3044958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of atropine administered in the medial septum or hippocampus on high- and low-frequency theta rhythms in the hippocampus of urethane anesthetized rats.
    Li S; Topchiy I; Kocsis B
    Synapse; 2007 Jun; 61(6):412-9. PubMed ID: 17372965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal transduction pathways. Molecular targets for lithium's actions.
    Manji HK; Potter WZ; Lenox RH
    Arch Gen Psychiatry; 1995 Jul; 52(7):531-43. PubMed ID: 7598629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.